The outlook for diagnostic purposes of the 2019‐novel coronavirus disease-Reference-Cited by-同舟云学术

The outlook for diagnostic purposes of the 2019‐novel coronavirus disease

Published:2020-05-26 Issue:12 Volume:235 Page:9211-9229
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Tahmasebi Safa¹,Khosh Elnaz²,Esmaeilzadeh Abdolreza³⁴^ORCID

Affiliation:

1. Department of Immunology, Health Faculty Tehran University of Medical Sciences Tehran Iran

2. Department of Immunology, School of Medicine Zanjan University of Medical Sciences Zanjan Iran

3. Department of Immunology Zanjan University of Medical Sciences Zanjan Iran

4. Cancer Gene Therapy Research Center Zanjan University of Medical Sciences Zanjan Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29804

Reference96 articles.

1. Abbott. (2020). Abbott launches molecular point‐of‐care test to detect novel coronavirus in as little as five minutes. Retrieved fromhttps://abbott.mediaroom.com/2020‐03‐27‐Abbott‐Launches‐Molecular‐Point‐of‐Care‐Test‐to‐Detect‐Novel‐Coronavirus‐in‐as‐Little‐as‐Five‐Minutes

2. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

3. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

4. Amanat F. Nguyen T. Chromikova V. Strohmeier S. Stadlbauer D. Javier A. …Krammer F.(2020).A serological assay to detect SARS‐CoV‐2 seroconversion in humans.MedRxiv https://doi.org/10.1101/2020.03.17.20037713

5. Evaluation of the pooling of swabs for real-time PCR detection of low titre shedding of low pathogenicity avian influenza in turkeys

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arts therapies for mental disorders in COVID-19 patients: a comprehensive review;Frontiers in Public Health;2023-12-04

2. Passive antibody therapy in emerging infectious diseases;Frontiers of Medicine;2023-12-02

3. Omicron: A SARS-CoV-2 Variant;New COVID-19 Variants [Working Title];2023-11-08

4. Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta‐analysis;International Journal of Rheumatic Diseases;2023-06-12

5. Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management;Vaccines;2023-01-11